← Evidence map

ArticleThe Journal of clinical and aesthetic dermatology2026

Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial Program.

Diego Ruiz Dasilva et al.PubMed ↗Full text ↗

No numbers read from the abstract.

Not cited yet

Venous Thromboembolism Risk in Patients with Atopic Dermatitis Treated with Abrocitinib: A Review of Female Patients on Oral Contraception and Nicotine Exposure From the JADE Clinical Trial Program. | OpenQuestion